Drug Profile
PC 515
Alternative Names: Carraguard; Lambda-carrageenan; PC-515Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Population Council (USA)
- Class Antivirals; Polysaccharides
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 31 Dec 2008 Discontinued - Phase-III for HIV infections in South Africa (Vaginal)
- 31 Mar 2007 The Population Council completes a phase III trial in South Africa
- 09 Aug 2004 Data presented at the 15th International AIDS Conference (IAC-2004) have been added to the Viral Infections antimicrobial activity section